Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy [Phase 3]
A Phase 3 randomized, active-controlled study comparing SHR-A1811 to Trastuzumab emtansine (T-DM1) in HER2-positive primary breast cancer wi…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer [NA]
A clinical trial is comparing standard surveillance with intensive surveillance in patients with early breast cancer and is currently recrui…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Heart Health After Cancer Treatment (HEART-ACT) [NA]
The HEART-ACT trial investigating heart health after cancer treatment for breast cancer patients is listed as active but not recruiting, wit…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse [Phase 3]
Phase 3 randomized trial comparing trastuzumab-deruxtecan to standard-of-care in early breast cancer patients with molecular relapse; curren…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction [NA]
A clinical trial update describing a study investigating disparities in cancer therapy–related inflammation and endothelial dysfunction in b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
A clinical trial update describing a study to quantify systemic immunosuppression to personalize cancer therapy and that the trial is curren…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Survival Monitoring in Russian Cancer Registries
An update on an active-not-recruiting clinical trial from N.N. Petrov National Medical Research Center of Oncology focusing on monitoring su…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer [Phase 2]
A Phase 2 trial update notes discontinuation of CDK4/6 inhibitors in patients with metastatic HR-positive, HER2-negative breast cancer.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer
This is a master protocol study in breast cancer exploring mechanobiology translation research, currently in the recruiting stage and led by…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AMXI-5001 in patients with advanced cancers, including breast, ovarian, prostate, and pancreatic cance…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Johns Hopkins Breast Cancer Program Longitudinal Repository
This entry provides an update on the Johns Hopkins Breast Cancer Program Longitudinal Repository trial. The study status is ACTIVE_NOT_RECRU…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer
A clinical study update for a PET imaging agent (18F-HER2 Affibody) evaluating HER2-expression in breast cancer; the trial is currently recr…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study
This clinical trial update evaluates triggering receptor expressed on myeloid cells-1 (TREM-1) as a novel biomarker in HER2-negative breast …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Integrin αvβ6-targeted PET in Malignant Tumors
A recruiting clinical trial evaluating an integrin αvβ6-targeted PET tracer for imaging malignant tumors, including non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Effects of Two Strength Exercise Programs on Upper Limb Functionality in Breast Cancer [NA]
A clinical trial is evaluating two strength exercise programs to improve upper limb function in breast cancer patients, and the study is not…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy [NA]
This clinical trial evaluates nursing-led communication using mobile health information for breast cancer patients undergoing concurrent che…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
TYK Medicines is conducting a Phase 1/2 study of TYK-00540 tablets in HR-positive, HER2-negative advanced breast cancer; the trial is curren…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
A clinical study using the PET imaging tracer 18F-FAPI-04 for breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer [Phase 2]
Phase 2 study evaluating trastuzumab deruxtecan versus endocrine therapy in HR-positive, HER2-low advanced breast cancer. The trial is curre…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors [Phase 1]
Phase 1 trial to evaluate tolerability and pharmacokinetics of TQB2101 in patients with advanced malignant tumors; the study is not yet recr…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy [Phase 3]
Phase 3 clinical trial comparing erector spinae plane block versus serratus anterior plane block for analgesia after modified radical mastec…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Genitourinary Syndrome of Menopause in Breast Cancer [NA]
A clinical trial sponsored by the University of Alcala is recruiting to study Genitourinary Syndrome of Menopause in women with breast cance…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics [NA]
Emory University is conducting a study to evaluate an evidence-based family history screening program designed to increase uptake of BRCA-as…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer [NA]
An ongoing clinical trial sponsored by the Medical College of Wisconsin is evaluating a lifestyle program for women with metastatic breast c…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
This clinical trial update examines how therapeutic care for metastatic breast cancer has evolved since 2008. The study is currently recruit…